Patency and complications of 2mm and 6mm polytetrafluoroethylene graft sizes in patients under hemodialysis

Phase 2

• Conditions: Condition 1: Kidney failure with hypertension. Condition 2: Renal failure.; Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease; Congenital renal failure; I12.0; P96.0

• Registration Number: IRCT20231212060340N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with kidney failure requiring chronic hemodialysis, as diagnosed by a nephrologist, who need an arm graft for hemodialysis access due to the lack of vascular access, as diagnosed by a vascular surgeon.

Exclusion Criteria

History of implantation of a graft in the same arm

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Graft patency. Timepoint: 6 months after intervention. Method of measurement: Clinical examination and successful hemodialysis.;Infection. Timepoint: 6 months after intervention. Method of measurement: Secretions culture.;Steal syndrome. Timepoint: 6 months after intervention. Method of measurement: Clinical signs including pain, coldness, sensory ataxia, and hand ulcer.;Pseudoaneurysm. Timepoint: 6 months after intervention. Method of measurement: Clinical examination.;Bleeding. Timepoint: 6 months after intervention. Method of measurement: Clinical examination.